Jinzhou, China

Xiangyang Yu

This inventor holds 1 USPTO granted patent. Top assignee: Bohai University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiangyang Yu. Retrieved from https://idiyas.com/inventor/xiangyang-yu-jx2vojsw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 23.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiangyang Yu: Innovator in Phage Research

Introduction

Xiangyang Yu is a notable inventor based in Jinzhou, China. He has made significant contributions to the field of phage research, particularly with his innovative work on virulent phages. His research focuses on the preparation and application of phages, which are crucial in controlling bacterial infections.

Latest Patents

Xiangyang Yu holds a patent for "Virulentphage φPf1901, and phage φPf901 preparation and application thereof." This invention provides a virulent phage φPf1901, which has an accession number of CCTCC M2019447. The virulent phage φPf1901 exhibits a titer of (1.4-3)×10 PFU/mL and an optimal multiplicity of infection (MOI) value of 0.0001. The phage demonstrates high specificity and lytic ability, making it effective in controlling bacterial hosts.

Career Highlights

Xiangyang Yu is affiliated with Bohai University, where he conducts his research and development in phage technology. His work has garnered attention for its potential applications in medical and agricultural fields. He has successfully developed a phage that can effectively target and eliminate specific bacterial strains.

Collaborations

Xiangyang Yu collaborates with esteemed colleagues, including Jian Zhang and Jianrong Li. Their combined expertise enhances the research output and innovation in phage applications.

Conclusion

Xiangyang Yu's contributions to phage research exemplify the importance of innovation in combating bacterial infections. His patented work on virulent phages showcases the potential for future advancements in this critical area of study.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…